🔴 Intravenous Infusions is trading 7.69% down today as no company-specific catalyst is confirmed

Intravenous Infusions is trading 7.69% down now at GHS 0.60, with no confirmed company-specific catalyst identified for the September 9 decline.

• The stock had another weak session on September 8, 2026.
• No announcement, earnings release, filing, or major transaction explaining the decline was identified.
• Broader risk-off conditions and healthcare weakness may have contributed, but evidence is insufficient to establish a direct cause.